Y－氨基丁酸的作用

1、鎮靜神經、抗焦慮。醫學家已經証明GABA是中樞神經系統的抑制性傳遞物質，是腦組織中最重要的神經遞質之一。其作用是降低神經元活性，防止神經細胞過熱。

2、降低血壓。GABA能作用於脊髓的血管運動中樞，有效促進血管擴張，達到降低血壓的目的。

3、治療疾病。

4、降低血氨。攝入GABA可以提高葡萄糖磷酸酯酶的活性，使腦細胞活動旺盛，可促進腦組織的新陳代謝和恢復腦細胞功能，改善神經機能。

5、提高腦活力。

GABA能進入腦內三羧酸循環，促進腦細胞代謝，同時還能提高葡萄糖代謝時葡萄糖磷酸酯酶的活性，增加乙酰膽碱的生成，擴張血管增加血流量，並降低血氨，促進大腦的新陳代謝，恢復腦細胞功能。

6、促進乙醇代謝。以嗜酒者為對象，服用GABA再飲用60ml威士忌后采血測定血中乙醇及 濃度，發現後者濃度明顯比對照組低。

7、GABA還具有防止皮膚老化、消除體臭、改善脂質代謝，防止動脈硬化高效減肥等功能。

產品詳詢：13657416805

1. References:
2. 1. 

   É. A. Bendikov and V. G. Butuzov, in: The Pharmacology of Monoaminergic Processes [in Russian], Moscow (1971), p. 24.

3. 2. 

   É. A. Bendikov and V. G. Butuzov, in: The Pharmacology of Monoaminergic Processes [in Russian], Moscow (1971), p. 42.

4. 3. 

   É. A. Bendikov and V. G. Butuzov, in: The Pharmacology of Monoaminergic Processes [in Russian], Moscow (1971), p. 53.

5. 4. 

   V. G. Butuzov and É. A. Bendikov, Farmakol. i Toksikol., No. 5, 535 (1969). 

6. 5. 

   N. A. Esayan, A. R. Armenyan, and L. N. Arakelyan, in: Problems in Biochemistry of the Brain [in Russian], part 3, Erevan (1967), p. 313.

7. 6. 

   V. V. Zakusov, Vestn. Akad. Med. Nauk SSSR, No. 4, 43 (1964).

8. 7. 

   V. V. Zakusov (editor), Sodium Hydroxybutyrate [in Russian], Moscow (1968).

9. 8. 

   N. V. Kaverina and Yu. B. Rozonov, Byull. Éksperim. Biol. i Med., No. 2, 60 (1966).

10. 9. 

    N. A. Kruglov and R. I. Kvasnoi, in: Sodium Hydroxybutyrate [in Russian], Moscow (1968), p. 48.

11. 10. 

    S. A. Mirzoyan, B. A. Kazaryan, and V. P. Akopyan, in: Current Problems in Pharmacology [in Russian], Kiev (1971), p. 184.

12. 11. 

    S. A. Mirzoyan and R. G. Boroyan, in: Problems in Biochemistry of the Brain [in Russian], part 3, Erevan (1967), p. 117.

13. 12. 

    R. U. Ostrovskaya, N. M. Tsybina, T. V. Protopopova, et al., Khim.-Farmets. Zh., No. 12, 21 (1969).

14. 13. 

    R. A. Khaunina and M. N. Maslova, in: Problems in Psychiatry and Neuropathology [in Russian], No. 13, Leningrad (1968), p. 583.

15. 14. 

    J. C. Eccles, The Physiology of Synapses, Springer, Berlin (1964).

16. 15. 

    D. P. Becker, H. F. Young, F. E. Nielsen, et al., Exp. Neurol.,24, 272 (1969).

17. 16. 

    D. R. Curtis, A. W. Duggon, and D. Felix, Brain Res.,23, 117 (1970). 

18. 17. 

    D. R. Curtis, D. Felix and H. McLenna, Brit. J. Pharmacol.,40, 881 (1970).

19. 18. 

    A. Halpern and G. Neck, United States Patent No. 3172, 8.12 (1965).

20. 19. 

    T. Hayashi, Hospital (Rio),75, 109 (1969).

21. 20. 

    H. Laborit, Internat. J. Neuropharmacol.,3, 433 (1964).